BBC vs. VPC
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and VPC (Virtus Private Credit ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while VPC is a Nontraditional Bonds fund tracking the Indxx Private Credit Index. Both are passively managed. Over the past 5 years, BBC returned -0.26%/yr vs 0.39%/yr for VPC. At a 0.36 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.75%/yr for VPC.
Performance
BBC vs. VPC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 25.75% return, which is significantly higher than VPC's -12.79% return.
BBC
- 1D
- 1.59%
- 1M
- 13.54%
- YTD
- 25.75%
- 6M
- 22.73%
- 1Y
- 156.95%
- 3Y*
- 27.00%
- 5Y*
- -0.26%
- 10Y*
- 11.15%
VPC
- 1D
- 0.41%
- 1M
- -3.76%
- YTD
- -12.79%
- 6M
- -11.42%
- 1Y
- -15.79%
- 3Y*
- 1.19%
- 5Y*
- 0.39%
- 10Y*
- —
BBC vs. VPC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 25.75% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 51.68% |
VPC Virtus Private Credit ETF | -12.79% | -6.75% | 10.52% | 22.20% | -11.70% | 34.18% | -9.50% | 9.25% |
Correlation
The correlation between BBC and VPC is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Feb 8, 2019 | 0.36 |
The correlation between BBC and VPC shifts across timeframes, from 0.19 (1 year) to 0.37 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. VPC — Risk / Return Rank
BBC
VPC
BBC vs. VPC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Private Credit ETF (VPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | VPC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +5.53 | ||
| Sortino ratioReturn per unit of downside risk | +6.31 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 0.82 | +0.74 |
| Calmar ratioReturn relative to maximum drawdown | 10.46 | -0.70 | +11.16 |
| Martin ratioReturn relative to average drawdown | 30.65 | -1.30 | +31.95 |
Loading charts...
Drawdowns
BBC vs. VPC - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than VPC's maximum drawdown of -53.45%. Use the drawdown chart below to compare losses from any high point for BBC and VPC.
Loading charts...
Drawdown Indicators
| BBC | VPC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -53.45% | -23.40% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -22.76% | +7.66% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -24.86% | -29.59% |
Max Drawdown (5Y)Largest decline over 5 years | -71.97% | -24.86% | -47.11% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -19.28% | -22.76% | +3.48% |
Average DrawdownAverage peak-to-trough decline | -37.08% | -7.76% | -29.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 12.20% | -7.06% |
Volatility
BBC vs. VPC - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 12.08% compared to Virtus Private Credit ETF (VPC) at 4.19%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than VPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | VPC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.08% | 4.19% | +7.89% |
Volatility (6M)Calculated over the trailing 6-month period | 26.79% | 11.26% | +15.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.27% | 13.50% | +22.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.52% | 13.56% | +25.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 20.52% | +17.23% |
BBC vs. VPC - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than VPC's 0.75% expense ratio.
Dividends
BBC vs. VPC - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.35%, less than VPC's 16.70% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.35% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
VPC Virtus Private Credit ETF | 16.70% | 14.33% | 11.26% | 11.71% | 10.74% | 6.31% | 10.06% | 8.19% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and VPC have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (12.08%) compared to VPC (4.19%). In terms of maximum drawdown, BBC dropped -76.85% vs VPC's -53.45%.
On 5-year performance, VPC leads with 0.39% vs -0.26% for BBC. On fees, VPC is cheaper at 0.75% per year. On volatility, VPC has been the lower-risk option at 4.19%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VPC has performed better with a 0.39% return vs -0.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VPC is cheaper with a 0.75% expense ratio, compared with 0.79% for BBC.
VPC has the higher dividend yield at 16.70%, compared with 1.35% for BBC.
BBC is categorized as Health & Biotech Equities, while VPC is Nontraditional Bonds. BBC tracks LifeSci Biotechnology Clinical Trials Index, while VPC tracks Indxx Private Credit Index. Their fees differ too: 0.79% for BBC and 0.75% for VPC.
BBC currently has the higher Sharpe Ratio (4.36 vs -1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and VPC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer